Cargando…
PARP1 inhibition elicits immune responses against non-small cell lung cancer
High levels of intracellular poly(ADP-ribose) (PAR) resulting from an elevated activity of PAR polymerase-1 (PARP1) correlate with poor infiltration of non-small cell lung cancers by cytotoxic T lymphocytes and dismal patient prognosis. Preclinical experimentation now demonstrates that PARP1 inhibit...
Autores principales: | Juncheng, Pan, Lafarge, Antoine, Kroemer, Guido, Castedo, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377245/ https://www.ncbi.nlm.nih.gov/pubmed/35979387 http://dx.doi.org/10.1080/2162402X.2022.2111915 |
Ejemplares similares
-
Pyridoxal kinase and poly(ADP-ribose) affect the immune microenvironment of locally advanced cancers
por: Joseph, Adrien, et al.
Publicado: (2021) -
An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells
por: Senovilla, Laura, et al.
Publicado: (2013) -
Cisplatin resistance coupled to enhanced sensitivity to metabolic interventions
por: Castedo, Maria, et al.
Publicado: (2018) -
Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancer
por: Juncheng, Pan, et al.
Publicado: (2022) -
Endogenous and exogenous glucocorticoids abolish the efficacy of immune-dependent cancer therapies
por: Ma, Yuting, et al.
Publicado: (2019)